Clinical trials in Novara – page 21

249 clinical trials in Novara, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in ItalyStudi-Clinici.it

Novara at a glance

249

clinical trials

Research sites1

Quick filters

249 trials in Novara

Open in trial search

Nasopharyngeal cancer

Not recruiting

Study of Pembrolizumab and Olaparib for Adults with Recurrent or Metastatic, Platinum-Resistant Nasopharyngeal Cancer

Registered drugNo placebo

Study of Pembrolizumab and Olaparib for Adults with Recurrent or Metastatic, Platinum-Resistant Nasopharyngeal Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Olaparib
Sponsor:Fondazione GONO Plus

Contact Research Centre

Basal cell carcinoma

Not recruiting

Study on Sonidegib for Patients with Locally Advanced Basal Cell Carcinoma

Registered drugNo placebo

Study on Sonidegib for Patients with Locally Advanced Basal Cell Carcinoma

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Sonidegib
Sponsor:Fondazione GONO Plus

Contact Research Centre

Breast cancer+1

Not recruiting

Study of PF-07220060 and Letrozole for Postmenopausal Women with HR-Positive, HER2-Negative Breast Cancer

Registered drugNo placebo

Study of PF-07220060 and Letrozole for Postmenopausal Women with HR-Positive, HER2-Negative Breast Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Letrozole
Sponsor:Pfizer Inc.

Contact Research Centre

Multiple sclerosis

Not recruiting

Study on the Effectiveness and Safety of Frexalimab and Teriflunomide in Adults with Relapsing Multiple Sclerosis

Registered drug

Study on the Effectiveness and Safety of Frexalimab and Teriflunomide in Adults with Relapsing Multiple Sclerosis

Registered drug

Italy

Participants:18–64 years
Substances:Colestyramine
Sponsor:Sanofi-Aventis Recherche & Developpement

Contact Research Centre

Anaplastic large cell lymphoma T- and null-cell types+2

Not recruiting

Study of Romidepsin and Drug Combination for Young Patients with Peripheral T-Cell Lymphomas Before Stem Cell Transplantation

InvestigationalNo placebo

Study of Romidepsin and Drug Combination for Young Patients with Peripheral T-Cell Lymphomas Before Stem Cell Transplantation

InvestigationalNo placebo

Italy

Participants:18–64 years
Substances:Romidepsin
Sponsor:Fondazione Italiana Linfomi Ets

Contact Research Centre

Bladder transitional cell carcinoma+2

Not recruiting

Study Comparing Sacituzumab Govitecan with Other Treatments for Patients with Advanced Unresectable Urothelial Cancer

Registered drugNo placebo

Study Comparing Sacituzumab Govitecan with Other Treatments for Patients with Advanced Unresectable Urothelial Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Docetaxel
Sponsor:Gilead Sciences Inc.

Contact Research Centre

Myelofibrosis+1

Not recruiting

Study of Pacritinib for Patients with Severe Thrombocytopenia in Myelofibrosis Conditions

Registered drugNo placebo

Study of Pacritinib for Patients with Severe Thrombocytopenia in Myelofibrosis Conditions

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Danazol
Sponsor:Sobi Inc.

Contact Research Centre

Mantle cell lymphoma stage II+2

Not recruiting

Study on Ibrutinib and Drug Combination for Patients with Generalized Mantle Cell Lymphoma

Registered drugNo placebo

Study on Ibrutinib and Drug Combination for Patients with Generalized Mantle Cell Lymphoma

Registered drugNo placebo

Italy

Participants:18–64 years
Substances:Ibrutinib
Sponsor:Klinikum der Universitaet Muenchen AöR

Contact Research Centre

Acute myocardial infarction

Not recruiting

Study on Evolocumab for Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention

Registered drugNo placebo

Study on Evolocumab for Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention

Registered drugNo placebo

Italy

Participants:18–64 years
Substances:Evolocumab
Sponsor:Assistance Publique Hopitaux De Paris

Contact Research Centre

Other cities in Italy

The busiest research cities in the country

All 237 cities in Italy

Clinical research in Novara

What the registry says about research in the country

01 Oncology Research

Clinical trials focusing on hematologic malignancies and solid tumors, investigating innovative treatments for various cancer types including leukemia, breast cancer, and lung cancer.

Advanced breast cancer therapies
Chronic myeloid leukemia treatments
Non-small cell lung cancer interventions

Studies evaluating combination therapies and targeted treatments to improve patient outcomes.

02 Cardiovascular Studies

Research focusing on heart failure prevention and treatment strategies, particularly exploring new drug combinations and their impact on cardiovascular outcomes.

Heart failure risk reduction
Cardiovascular death prevention
Chronic kidney disease management

Innovative approaches combining multiple therapeutic agents to address cardiovascular risks.

03 Autoimmune Conditions

Investigations into treatments for various autoimmune disorders, including Sjögren's Syndrome and rheumatoid arthritis, with emphasis on novel therapeutic approaches.

Biomarker-guided treatments
Long-term safety evaluations
Innovative therapeutic combinations

Focus on developing targeted therapies for better disease management and patient care.

Back to Italy All countries